P

Protalix Biotherapeutics Inc
AMEX:PLX

Watchlist Manager
Protalix Biotherapeutics Inc
AMEX:PLX
Watchlist
Price: 1.54 USD 1.99% Market Closed
Market Cap: 122.6m USD

Intrinsic Value

The intrinsic value of one PLX stock under the Base Case scenario is 11.13 USD. Compared to the current market price of 1.54 USD, Protalix Biotherapeutics Inc is Undervalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PLX Intrinsic Value
11.13 USD
Undervaluation 86%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Protalix Biotherapeutics Inc

What is Valuation History?
Compare PLX to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PLX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Protalix Biotherapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Protalix Biotherapeutics Inc

Current Assets 60.5m
Cash & Short-Term Investments 19.5m
Receivables 4.7m
Other Current Assets 36.4m
Non-Current Assets 13.4m
PP&E 10m
Other Non-Current Assets 3.4m
Efficiency

Free Cash Flow Analysis
Protalix Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Protalix Biotherapeutics Inc

Revenue
59.8m USD
Cost of Revenue
-29.9m USD
Gross Profit
29.9m USD
Operating Expenses
-25.2m USD
Operating Income
4.6m USD
Other Expenses
-720k USD
Net Income
3.9m USD
Fundamental Scores

PLX Profitability Score
Profitability Due Diligence

Protalix Biotherapeutics Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
ROIC is Increasing
Operating Margin is Increasing
Healthy Gross Margin
51/100
Profitability
Score

Protalix Biotherapeutics Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

PLX Solvency Score
Solvency Due Diligence

Protalix Biotherapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Interest Coverage
49/100
Solvency
Score

Protalix Biotherapeutics Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PLX Price Targets Summary
Protalix Biotherapeutics Inc

There are no price targets for PLX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Protalix Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PLX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PLX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PLX stock?

The intrinsic value of one PLX stock under the Base Case scenario is 11.13 USD.

Is PLX stock undervalued or overvalued?

Compared to the current market price of 1.54 USD, Protalix Biotherapeutics Inc is Undervalued by 86%.

Back to Top